{"id":523,"date":"2023-10-04T19:33:48","date_gmt":"2023-10-04T19:33:48","guid":{"rendered":"https:\/\/vigilantbiosciences.com\/?p=523"},"modified":"2023-10-11T19:35:24","modified_gmt":"2023-10-11T19:35:24","slug":"bevigilant-orafusion-system-released-in-italy","status":"publish","type":"post","link":"https:\/\/vigilantbiosciences.com\/nl\/bevigilant-orafusiesysteem-uitgebracht-in-italie\/","title":{"rendered":"BeVigilant\u2122 OraFusion\u2122-systeem uitgebracht in Itali\u00eb"},"content":{"rendered":"<p>[et_pb_section fb_built=\u201d1\u2033 _builder_version=\u201d4.16\u2033locked=\u201doff\u201d global_colors_info=\u201d{}\u201d][et_pb_row _builder_version=\u201d4.16\u2033 background_size=\u201dinitial\u201d background_position=\u201dtop_left\u201d background_repeat=\u201drepeat\u201d global_colors_info=\u201d{ }\u201d][et_pb_column type=\u201d4_4\u2033 _builder_version=\u201d4.16\u2033 custom_padding=\u201d|||\u201d global_colors_info=\u201d{}\u201d custom_padding__hover=\u201d|||\u201d][et_pb_text _builder_version=\u201d4.22.2\u2033 header_2_font_size=\u201d24px\u201d header_2_line_height=\u201d1.4em\u201d background_size=\u201dinitial\u201d background_position=\u201dtop_left\u201d background_repeat=\u201drepeat\u201d custom_padding =\u201d25px||||false|false\u201d global_colors_info=\u201d{}\u201d]<\/p>\n<h2>Waakzame biowetenschappen leidt de aanval tegen mondkanker<\/h2>\n<p>Lakeway, Texas (4 oktober 2023) \u2013 Vigilant Biosciences\u00ae, Inc. (\u201cVigilant\u201d), een toonaangevende ontwikkelaar van geavanceerde oplossingen die de detectie van mondkanker versnellen, kondigt de release aan van zijn vlaggenschipproduct, de BeVigilant\u2122 OraFusion\u2122-systeem, in Itali\u00eb. <\/p>\n<p>Het BeVigilant\u2122 OraFusion\u2122-systeem is een baanbrekend apparaat dat op de zorgplek een orale kankerrisicobeoordeling uitvoert. Het systeem levert een nauwkeurig resultaat van de risicobeoordeling door de gecombineerde analyse van biomarkerconcentraties in een vroeg stadium en intelligente, door software aangedreven evaluatie van klinische risicofactoren. Deze ge\u00efntegreerde analyse voorziet eerstelijnsartsen van de noodzakelijke gegevens om weloverwogen behandelbeslissingen te nemen voor pati\u00ebnten met orale laesies.<\/p>\n<p>\u201cVanaf het begin heeft Vigilant ernaar gestreefd de overlevingskans van mondkanker te verhogen door middel van vroege detectie en interventie\u201d, aldus Bill Brodie, CEO van Vigilant Biosciences\u00ae. \u201cHet BeVigilant\u2122 OraFusion\u2122-systeem brengt dit doel tot bloei en helpt artsen bij de beoordeling van mondkanker deze eerder dan ooit tevoren op te sporen. Door de volgende stap te zetten in het hervormen van de detectie van mondkanker, geloven we dat onze technologie hoop en levensreddende resultaten zal brengen voor degenen die door deze ziekte zijn getroffen.\u201d<\/p>\n<p>Wanneer pati\u00ebnten in de vroege stadia van mondkanker worden doorverwezen naar gespecialiseerde zorg, is de behandeling vaak minder invasief en effectiever, wat tot aanzienlijk betere resultaten leidt. Het huidige overlevingspercentage voor mondkanker is 50%, maar vroege detectie kan het overlevingspercentage aanzienlijk verhogen tot 90%. <\/p>\n<p>Vigilant Biosciences\u00ae blijft voorop lopen in de strijd tegen mondkanker met eenvoudige, nauwkeurige en kosteneffectieve oplossingen die vroege detectie, effectieve interventie en betere resultaten mogelijk maken. Voor meer informatie over Vigilant Biosciences\u00ae en zijn producten kunt u terecht op <a href=\"https:\/\/vigilantbiosciences.com\/nl\/\">https:\/\/vigilantbiosciences.com\/<\/a>. <\/p>\n<p>Opmerking: Het BeVigilant\u2122 OraFusion\u2122-systeem is niet verkrijgbaar in de VS<\/p>\n<p><strong>Over Vigilant Biosciences\u00ae, Inc.<\/strong><br \/>\nVigilant Biosciences\u00ae is een toonaangevende innovator en ontwikkelaar van oplossingen die artsen helpen bij de vroege detectie van mondkanker. De BeVigilant\u2122-productlijn van Vigilant omvat point-of-care-testen die eenvoudig, nauwkeurig en kosteneffectief zijn, waardoor zorgverleners levens kunnen verbeteren door eerdere interventies. Meer informatie over Vigilant Biosciences\u00ae vindt u op <a href=\"https:\/\/vigilantbiosciences.com\/nl\/\">https:\/\/vigilantbiosciences.com\/<\/a>.[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"<p>Vigilant Biosciences\u00ae leidt de strijd tegen mondkanker Lakeway, Texas (4 oktober 2023) \u2013 Vigilant Biosciences\u00ae, Inc. (\u201cVigilant\u201d), een toonaangevende ontwikkelaar van geavanceerde oplossingen die de detectie van mondkanker versnellen, kondigt de release aan van zijn vlaggenschipproduct, het BeVigilant\u2122 OraFusion\u2122-systeem, in Itali\u00eb. Het BeVigilant\u2122 OraFusion\u2122-systeem is een baanbrekend apparaat dat een [\u2026]<\/p>","protected":false},"author":3,"featured_media":527,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae<\/title>\n<meta name=\"description\" content=\"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vigilantbiosciences.com\/nl\/bevigilant-orafusiesysteem-uitgebracht-in-italie\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae\" \/>\n<meta property=\"og:description\" content=\"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vigilantbiosciences.com\/nl\/bevigilant-orafusiesysteem-uitgebracht-in-italie\/\" \/>\n<meta property=\"og:site_name\" content=\"Vigilant Biosciences\u00ae\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/VigilantBiosciences1\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-04T19:33:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-11T19:35:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/dentist-with-patient-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"dex.manley\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"dex.manley\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\"},\"author\":{\"name\":\"dex.manley\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357\"},\"headline\":\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy\",\"datePublished\":\"2023-10-04T19:33:48+00:00\",\"dateModified\":\"2023-10-11T19:35:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\"},\"wordCount\":431,\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\",\"name\":\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\"},\"datePublished\":\"2023-10-04T19:33:48+00:00\",\"dateModified\":\"2023-10-11T19:35:24+00:00\",\"description\":\"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.\",\"breadcrumb\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/vigilantbiosciences.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BeVigilant\u2122 OraFusion\u2122 System Released in Italy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"name\":\"Vigilant Biosciences\u00ae\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vigilantbiosciences.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\",\"name\":\"Vigilant Biosciences\u00ae\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"contentUrl\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Vigilant Biosciences\u00ae\"},\"image\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/VigilantBiosciences1\",\"https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357\",\"name\":\"dex.manley\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g\",\"caption\":\"dex.manley\"},\"url\":\"https:\/\/vigilantbiosciences.com\/nl\/author\/dex-manley\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae","description":"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vigilantbiosciences.com\/nl\/bevigilant-orafusiesysteem-uitgebracht-in-italie\/","og_locale":"nl_NL","og_type":"article","og_title":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae","og_description":"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.","og_url":"https:\/\/vigilantbiosciences.com\/nl\/bevigilant-orafusiesysteem-uitgebracht-in-italie\/","og_site_name":"Vigilant Biosciences\u00ae","article_publisher":"https:\/\/www.facebook.com\/VigilantBiosciences1","article_published_time":"2023-10-04T19:33:48+00:00","article_modified_time":"2023-10-11T19:35:24+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/dentist-with-patient-1.jpg","type":"image\/jpeg"}],"author":"dex.manley","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"dex.manley","Geschatte leestijd":"2 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#article","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/"},"author":{"name":"dex.manley","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357"},"headline":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy","datePublished":"2023-10-04T19:33:48+00:00","dateModified":"2023-10-11T19:35:24+00:00","mainEntityOfPage":{"@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/"},"wordCount":431,"publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"articleSection":["News"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/","url":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/","name":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy - Vigilant Biosciences\u00ae","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/#website"},"datePublished":"2023-10-04T19:33:48+00:00","dateModified":"2023-10-11T19:35:24+00:00","description":"Vigilant Biosciences\u00ae, a developer of technology to detect oral cancer, announces the release of the BeVigilant\u2122 OraFusion\u2122 System in Italy.","breadcrumb":{"@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vigilantbiosciences.com\/bevigilant-orafusion-system-released-in-italy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vigilantbiosciences.com\/"},{"@type":"ListItem","position":2,"name":"BeVigilant\u2122 OraFusion\u2122 System Released in Italy"}]},{"@type":"WebSite","@id":"https:\/\/vigilantbiosciences.com\/#website","url":"https:\/\/vigilantbiosciences.com\/","name":"Vigilant Biosciences\u00ae","description":"","publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vigilantbiosciences.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/vigilantbiosciences.com\/#organization","name":"Vigilant Biosciences\u00ae","url":"https:\/\/vigilantbiosciences.com\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/","url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","contentUrl":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","width":"1024","height":"1024","caption":"Vigilant Biosciences\u00ae"},"image":{"@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/VigilantBiosciences1","https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/"]},{"@type":"Person","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357","name":"dex.manley","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g","caption":"dex.manley"},"url":"https:\/\/vigilantbiosciences.com\/nl\/author\/dex-manley\/"}]}},"_links":{"self":[{"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/posts\/523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/comments?post=523"}],"version-history":[{"count":0,"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/posts\/523\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/media\/527"}],"wp:attachment":[{"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/media?parent=523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/categories?post=523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/nl\/wp-json\/wp\/v2\/tags?post=523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}